Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Kershaw

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Cancers|October 31, 2020
Challenges and Opportunities for Effective Cancer ImmunotherapiesClare Y Slaney, Michael H Kershaw
Journal of Leukocyte Biology|February 25, 2010
Genetic redirection of T cells for cancer therapyJennifer A Westwood, Michael H Kershaw
Cancer Immunology, Immunotherapy : CII|July 27, 2014
Foxp3 expression in T regulatory cells and other cell lineagesChristel Devaud, Phillip K Darcy, Michael H Kershaw
Nature Biotechnology|November 5, 2002
Dual-specific T cells combine proliferation and antitumor activityMichael H Kershaw, Jennifer A Westwood, Patrick Hwu
Cancers|February 25, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and ChallengesEvan G Pappas, Michael H Kershaw, Clare Y Slaney
Immunotherapy|July 20, 2010
Genetic modification of natural killer cells for adoptive cellular immunotherapyHollie J Pegram, Michael H Kershaw, Phillip K Darcy
Oncoimmunology|December 20, 2013
Blockade of PD-1 immunosuppression boosts CAR T-cell therapyLiza B John, Michael H Kershaw, Phillip K Darcy
Oncoimmunology|January 23, 2015
The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapyJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Cancer Research|December 6, 2014
Trafficking of T cells into tumorsClare Y Slaney, Michael H Kershaw, Phillip K Darcy
Nature Reviews. Cancer|July 25, 2013
Gene-engineered T cells for cancer therapyMichael H Kershaw, Jennifer A Westwood, Phillip K Darcy
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Cancers|October 31, 2020
Challenges and Opportunities for Effective Cancer ImmunotherapiesClare Y Slaney, Michael H Kershaw
Journal of Leukocyte Biology|February 25, 2010
Genetic redirection of T cells for cancer therapyJennifer A Westwood, Michael H Kershaw
Cancer Immunology, Immunotherapy : CII|July 27, 2014
Foxp3 expression in T regulatory cells and other cell lineagesChristel Devaud, Phillip K Darcy, Michael H Kershaw
Nature Biotechnology|November 5, 2002
Dual-specific T cells combine proliferation and antitumor activityMichael H Kershaw, Jennifer A Westwood, Patrick Hwu
Cancers|February 25, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and ChallengesEvan G Pappas, Michael H Kershaw, Clare Y Slaney
Immunotherapy|July 20, 2010
Genetic modification of natural killer cells for adoptive cellular immunotherapyHollie J Pegram, Michael H Kershaw, Phillip K Darcy
Oncoimmunology|December 20, 2013
Blockade of PD-1 immunosuppression boosts CAR T-cell therapyLiza B John, Michael H Kershaw, Phillip K Darcy
Oncoimmunology|January 23, 2015
The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapyJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Cancer Research|December 6, 2014
Trafficking of T cells into tumorsClare Y Slaney, Michael H Kershaw, Phillip K Darcy
Nature Reviews. Cancer|July 25, 2013
Gene-engineered T cells for cancer therapyMichael H Kershaw, Jennifer A Westwood, Phillip K Darcy
Pageof 10